NISHITH.TV
  • Mumbai
  • Silicon Valley
  • Bengaluru
  • Singapore
  • Mumbai BKC
  • New Delhi
  • Munich
  • New York

Locations

  • Mumbai
  • Silicon Valley
  • Bengaluru
  • Singapore
  • Mumbai BKC
  • New Delhi
  • Munich
  • New York
  • Content
  • Home
  • ABOUT US
  • NDA in the Media
  • Areas of Service
  • Research and Articles
  • Opportunities
  • Contact
  • NDACloud
  • Client Access
  • Member Access
  • Events and Calender
  • How we perform
  • Knowledge anywhere, anytime
  • See our recent deals
  • Up to date legal developments
  • Case studies in M&A

Research and Articles


  • Research at NDA
  • Research Papers
  • Research Articles
  • NDA Think Tanks
  • NDA Hotline
  • New Ali Gunjan
  • Japan Desk ジャパンデスク

NDA-Hotline


  • Debt Funding in India Series
  • Private Equity Corner
  • The Startups Series
  • Court Corner
  • Investment Funds: Monthly Digest
  • Insolvency and Bankruptcy Hotline
  • Deal Destination
  • New Publication
  • M&A Interactive
  • Lit Corner
  • Private Debt Hotline
  • Food & Beverages Hotline
  • Companies Act Series
  • Gaming Law Wrap
  • Private Client Wrap
  • GIFT City Express
  • Regulatory Hotline
  • Capital Markets Hotline
  • Tax Hotline
  • Corpsec Hotline
  • Dispute Resolution Hotline
  • M&A Hotline
  • Pharma & Healthcare Update
  • Competition Law Hotline
  • HR Law Hotline
  • IP Hotline
  • Telecom Hotline
  • FEMA Hotline
  • Social Sector Hotline
  • iCe Hotline
  • SEZ Hotline
  • Media Hotline
  • Funds Hotline
  • Education Sector Hotline
  • International Trade Hotlines
  • Other Hotline
  • Real Estate Update
  • Realty Check
  • White Collar and Investigations Practice
  • Legal Update
  • IP Lab
  • Cross Examination
  • Technology & Tax Series
  • Technology Law Analysis
  • Yes, Governance Matters.
  • Financial Service Update
  • Japan Desk ジャパンデスク

Pharma & Healthcare Update

1234
TITLE 
DATE 
Pay To Participants For Research Related Injuries- Suggests ICMR
11-26-2008
Patentee to be heard in proceedings for compulsory licensing for export
07-08-2008
Novartis' Challenge To Section 3(d) Of Patents Act Dismissed
08-10-2007
Government contemplating to allow Phase I trials in India
08-09-2007
Mashelkar Committee submits its report on patentability of NCE's and micro-organisms
01-18-2007
Recent Mumbai High Court Rulings on Drug Regulations
05-11-2006
Guidelines for Medical Devices notified as "Drugs"
03-02-2006
New Bill to regulate scientific research on humans
12-15-2005
Destination India: Fastest growing Asian hub for clinical trials
10-14-2005
In Pipeline: New Drug policy
08-12-2005
Should Phase 1 Trials be permitted in India? - Debate continues
11-15-2003
First Exclusive Marketing Rights granted to Indian Pharmaceutical Company
09-25-2003

Mission and Vision


Distinctly Different

What's New


Mid-year Regulatory Update 2022: Medical Device Industry in India
Pharma & Healthcare Update: June 28,2022
Mid-year Update: Digital Health in India
Pharma & Healthcare Update : June 27,2022

Events


Webinars

Sustainable Mobility: Opportunities and Challenges
June 09,2022 - June 09,2022

This event is over. For event material please click here


Seminar

Navigating Disputes in India
February 26,2020 - February 26,2020

This event is over. For event material please click here


Round Table

Investing In Net Zero
July 14,2022 - July 14,2022

News Roundup


News Articles

Impact of Supreme Court’s new covidvaccination ruling on India’s employers
May 13,2022

Quotes

TCS case may throw spotlight on job termination in IT industry
June 23,2022

Newsletters


Pharma & Healthcare Update

Mid-year Regulatory Update 2022: Medical Device Industry in India
June 28,2022

Pharma & Healthcare Update

Mid-year Update: Digital Health in India
June 27,2022

Social Sector Hotline

Roe v. Wade Overruled, NGOs may face reduced international funding
June 27,2022

  • Disclaimer
  • Content
  • Feedback
  • Walkthrough
  • Subscribe
Nishith Desai Associates@2016 All rights reserved.